The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease

European Journal of Immunology

Volumn 44, Issue 11, 2014, Pages 3156-3165

  Kolwijck, Eva ^a   van de Veerdonk, Frank L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Allergic bronchopulmonary aspergillosis; Aspergillosis; Immune regulation; Mycobiome

Indexed keywords

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASTHMA; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; LUNG; LUNG ASPERGILLOSIS; MICROBIOLOGY; MICROFLORA; PATHOGENICITY; PATHOLOGY;

ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; ASTHMA; HUMANS; IMMUNOCOMPROMISED HOST; INVASIVE PULMONARY ASPERGILLOSIS; LUNG; MICROBIOTA;

EID: 84916885259     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344404     Document Type: Review

References (87)

1. Schaffner, A., Douglas, H. and Braude, A., Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 1982. 69: 617-631.
2. Meersseman, W. and Van Wijngaerden, E., Invasive aspergillosis in the ICU: an emerging disease. Intensive Care Med. 2007. 33: 1679-1681.
3. Wauters, J., Baar, I., Meersseman, P., Meersseman, W., Dams, K., De Paep, R., Lagrou, K. et al., Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med. 2012. 38: 1761-1768.
4. Rapaka, R. R. and Kolls, J. K., Pathogenesis of allergic bronchopulmonary aspergillosis in cystic fibrosis: current understanding and future directions. Med. Mycol. 2009. 47(Suppl 1): S331-S337.
5. Beck, J. M., Young, V. B. and Huffnagle, G. B., The microbiome of the lung. Transl. Res. 2012. 160: 258-266.
6. Marsland, B. J., Yadava, K. and Nicod, L. P., The airway microbiome and disease. Chest 2013. 144: 632-637.
7. Morgan, X. C. and Huttenhower, C., Chapter 12: human microbiome analysis. PLoS Comput. Biol. 2012. 8: e1002808.
8. Erb-Downward, J. R., Thompson, D. L., Han, M. K., Freeman, C. M., McCloskey, L., Schmidt, L. A., Young, V. B. et al., Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One 2011. 6: e16384.
9. Segal, B. H., Aspergillosis. N. Engl. J. Med. 2009. 360: 1870-1884.
10. Baddley, J. W., Andes, D. R., Marr, K. A., Kontoyiannis, D. P., Alexander, B. D., Kauffman, C. A., Oster, R. A. et al., Factors associated with mortality in transplant patients with invasive aspergillosis. Clin. Infect. Dis. 2010. 50: 1559-1567.
11. Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J. et al., Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis. 2010. 50: 1091-1100.
12. Park, S. J., Hughes, M. A., Burdick, M., Strieter, R. M. and Mehrad, B., Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis. J. Immunol. 2009. 182: 4306-4312.
13. Smith, N. L. and Denning, D. W., Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma. Eur. Respir. J. 2011. 37: 865-872.
14. Latzin, P., Hartl, D., Regamey, N., Frey, U., Schoeni, M. H. and Casaulta, C., Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur. Respir. J. 2008. 31: 36-42.
15. Hartl, D., Buckland, K. F. and Hogaboam, C. M., Chemokines in allergic aspergillosis-from animal models to human lung diseases. Inflamm. Allergy Drug Targets 2006. 5: 219-228.
16. Hartl, D., Immunological mechanisms behind the cystic fibrosis-ABPA link. Med. Mycol. 2009. 47(Suppl 1): S183-S191.
17. Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C. et al., Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008. 455: 1109-1113.
18. Abdollahi-Roodsaz, S., Joosten, L. A., Koenders, M. I., Devesa, I., Roelofs, M. F., Radstake, T. R., Heuvelmans-Jacobs, M. et al., Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Invest. 2008. 118: 205-216.
19. Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C. et al., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009. 461: 1282-1286.
20. Huffnagle, G. B. and Noverr, M. C., The emerging world of the fungal microbiome. Trends Microbiol. 2013. 21: 334-341.
21. Iliev, I. D., Funari, V. A., Taylor, K. D., Nguyen, Q., Reyes, C. N., Strom, S. P., Brown, J. et al., Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 2012. 336: 1314-1317.
22. van de Veerdonk, F. L., Marijnissen, R. J., Kullberg, B. J., Koenen, H. J., Cheng, S. C., Joosten, I., van den Berg, W. B. et al., The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009. 5: 329-340.
23. Hemdan, N. Y., Birkenmeier, G., Wichmann, G., Abu El-Saad, A. M., Krieger, T., Conrad, K. and Sack, U., Interleukin-17-producing T helper cells in autoimmunity. Autoimmun. Rev. 2010. 9: 785-792.
24. Marijnissen, R. J., Koenders, M. I., van de Veerdonk, F. L., Dulos, J., Netea, M. G., Boots, A. M., Joosten, L. A. et al., Exposure to Candida albicans polarizes a T-cell driven arthritis model towards Th17 responses, resulting in a more destructive arthritis. PLoS One 2012. 7: e38889.
25. Smeekens, S. P., van de Veerdonk, F. L., van der Meer, J. W. M., Kullberg, B. J., Joosten, L. A. B. and Netea, M. G., The Candida T(h)17 response is dependent on mannan- and beta-glucan-induced prostaglandin E2. Int. Immunol. 2010. 22: 889-895.
26. Kim, Y. G., Udayanga, K. G., Totsuka, N., Weinberg, J. B., Nunez, G. and Shibuya, A., Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE(2). Cell Host Microbe 2014. 15: 95-102.
27. Ghannoum, M. A., Jurevic, R. J., Mukherjee, P. K., Cui, F., Sikaroodi, M., Naqvi, A. and Gillevet, P. M., Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010. 6: e1000713.
28. Monteiro-da-Silva, F., Araujo, R. and Sampaio-Maia, B., Interindividual variability and intraindividual stability of oral fungal microbiota over time. Med. Mycol. 2014. 52: 498-505.
29. Charlson, E. S., Diamond, J. M., Bittinger, K., Fitzgerald, A. S., Yadav, A., Haas, A. R., Bushman, F. D. et al., Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. Am. J. Respir. Crit Care Med. 2012. 186: 536-545.
30. Gresnigt, M. S., Becker, K. L., Smeekens, S. P., Jacobs, C. W. M., Joosten, L. A. B., van der Meer, J. W. M., Netea, M. G. et al., Aspergillus fumigatus-induced IL-22 is not restricted to a specific Th cell subset and is dependent on complement receptor 3. J. Immunol. 2013. 190: 5629-5639.
31. Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K. and Sabat, R., IL-22 increases the innate immunity of tissues. Immunity 2004. 21: 241-254.
32. Behnsen, J., Jellbauer, S., Wong, C. P., Edwards, R. A., George, M. D., Ouyang, W. and Raffatellu, M., The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity 2014. 40: 262-273.
33. Ader, F., Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal disease. Curr. Infect. Dis. Rep. 2010. 12: 409-416.
34. Barberan, J., Sanz, F., Hernandez, J. L., Merlos, S., Malmierca, E., Garcia-Perez, F. J., Sanchez-Haya, E. et al., Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by gold stage. J. Infect. 2012. 65: 447-452.
35. Sze, M. A., Dimitriu, P. A., Hayashi, S., Elliott, W. M., McDonough, J. E., Gosselink, J. V., Cooper, J. et al., The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012. 185: 1073-1080.
36. Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C. and Isaacson, R. E., The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 2012. 7: e47305.
37. Afessa, B., Morales, I. J., Scanlon, P. D. and Peters, S. G., Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure. Crit. Care Med. 2002. 30: 1610-1615.
38. Barberan, J., Alcazar, B., Malmierca, E., Garcia de la Llana, F., Dorca, J., Del Castillo, D., Villena, V. et al., Repeated Aspergillus isolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection? BMC Infect. Dis. 2012. 12: 295.
39. Guinea, J., Torres-Narbona, M., Gijon, P., Munoz, P., Pozo, F., Pelaez, T., de Miguel, J. et al., Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin. Microbiol. Infect. 2010. 16: 870-877.
40. Huerta, A., Soler, N., Esperatti, M., Guerrero, M., Menendez, R., Gimeno, A., Zalacain, R. et al., Importance of Aspergillus spp. isolation in acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study. Respir. Res. 2014. 15: 17.
41. Rouze, A., Cottereau, A. and Nseir, S., Chronic obstructive pulmonary disease and the risk for ventilator-associated pneumonia. Curr. Opin. Crit. Care 2014. 20: 525-531.
42. Vehreschild, J. J., Brockelmann, P. J., Bangard, C., Verheyen, J., Vehreschild, M. J., Michels, G., Wisplinghoff, H. et al., Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. Epidemiol. Infect. 2012. 140: 1848-1852.
43. Kim, S. H., Kim, M. N., Lee, S. O., Choi, S. H., Kim, Y. S., Woo, J. H., Lim, C. M. et al., Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis. Mycoses 2012. 55: 189-192.
44. Hoyo-Ulloa, I., Cobos-Trigueros, N., Puig-de la Bellacasa, J. and Martinez-Martinez, J. A., Influenza A (H1N1) complicated by invasive aspergillosis in non-severely immunocompromised patients. Enferm. Infecc. Microbiol. Clin. 2012. 30: 583-584.
45. Lat, A., Bhadelia, N., Miko, B., Furuya, E. Y. and Thompson, G. R., 3rd, Invasive aspergillosis after pandemic (H1N1) 2009. Emerg. Infect. Dis. 2010. 16: 971-973.
46. Leung, R. K., Zhou, J. W., Guan, W., Li, S. K., Yang, Z. F. and Tsui, S. K., Modulation of potential respiratory pathogens by pH1N1 viral infection. Clin. Microbiol. Infect. 2013. 19: 930-935.
47. Lynch, S. V., Viruses and microbiome alterations. Ann Am. Thorac Soc. 2014. 11(Suppl 1): S57-S60.
48. Noverr, M. C., Noggle, R. M., Toews, G. B. and Huffnagle, G. B., Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 2004. 72: 4996-5003.
49. van Woerden, H. C., Gregory, C., Brown, R., Marchesi, J. R., Hoogendoorn, B. and Matthews, I. P., Differences in fungi present in induced sputum samples from asthma patients and non-atopic controls: a community based case control study. BMC Infect. Dis. 2013. 13: 69.
50. Fisher, G. J., Yang, J., Palmer, J., Dagenais, T., Huang, X., Hammock, B. and Keller, N. P., Aspergillus lipoxygenase: a novel instigator of asthma? Abstract 142, 6th Advances Against Aspergillosis Conference, Madrid, Spain 2014. Available at: http://www.asperweb.co.uk.
51. Valenza, G., Tappe, D., Turnwald, D., Frosch, M., Konig, C., Hebestreit, H. and Abele-Horn, M., Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J. Cyst. Fibros. 2008. 7: 123-127.
52. Lipuma, J. J., The changing microbial epidemiology in cystic fibrosis. Clin. Microbiol. Rev. 2010. 23: 299-323.
53. Gollwitzer, E. S. and Marsland, B. J., Microbiota abnormalities in inflammatory airway diseases-potential for therapy. Pharmacol. Ther. 2014. 141: 32-39.
54. LiPuma, J., The new microbiology of cystic fibrosis: it takes a community. Thorax 2012. 67: 851-852.
55. Rogers, G. B., Stressmann, F. A., Walker, A. W., Carroll, M. P. and Bruce, K. D., Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity. Expert. Rev. Mol. Diagn. 2010. 10: 187-196.
56. Amin, R., Dupuis, A., Aaron, S. D. and Ratjen, F., The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 2010. 137: 171-176.
57. Mowat, E., Rajendran, R., Williams, C., McCulloch, E., Jones, B., Lang, S. and Ramage, G., Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation. FEMS Microbiol. Lett. 2010. 313: 96-102.
58. Baxter, C. G., Rautemaa, R., Jones, A. M., Webb, A. K., Bull, M., Mahenthiralingam, E. and Denning, D. W., Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum. Thorax 2013. 68: 652-657.
59. Eickmeier, O., Rieber, N., Eckrich, J., Hector, A., Graeppler-Mainka, U. and Hartl, D., Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease. Curr. Pharm. Des. 2013. 19: 3669-3678.
60. Olszak, T., An, D., Zeissig, S., Vera, M. P., Richter, J., Franke, A., Glickman, J. N. et al., Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012. 336: 489-493.
61. Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G. et al., Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011. 331: 337-341.
62. Ivanov, II, Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D. et al., Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009. 139: 485-498.
63. Ivanov, II, Frutos Rde, L., Manel, N., Yoshinaga, K., Rifkin, D. B., Sartor, R. B., Finlay, B. B. et al., Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008. 4: 337-349.
64. Gresnigt, M. S., Netea, M. G. and van de Veerdonk, F. L., Pattern recognition receptors and their role in invasive aspergillosis. Ann. N. Y. Acad. Sci. 2012. 1273: 60-67.
65. Werner, J. L., Metz, A. E., Horn, D., Schoeb, T. R., Hewitt, M. M., Schwiebert, L. M., Faro-Trindade, I. et al., Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 2009. 182: 4938-4946.
66. Werner, J. L., Gessner, M. A., Lilly, L. M., Nelson, M. P., Metz, A. E., Horn, D., Dunaway, C. W. et al., Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection. Infect. Immun. 2011. 79: 3966-3977.
67. Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., Belladonna, M. L. et al., IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 2007. 37: 2695-2706.
68. Zelante, T., Bozza, S., De Luca, A., D'Angelo, C., Bonifazi, P., Moretti, S., Giovannini, G. et al., Th17 cells in the setting of Aspergillus infection and pathology. Med. Mycol. 2009. 47(Suppl 1): S162-S169.
69. Way, E. E., Chen, K. and Kolls, J. K., Dysregulation in lung immunity-the protective and pathologic Th17 response in infection. Eur. J. Immunol. 2013. 43: 3116-3124.
70. Schott, B., Martin, R. A., Ather, J. L. and Poynter, E., Segmented filamentous bacteria colonization does not alter responses to allergic airway sensitization and challange. Annals ATS 2014. 11: S78-S79.
71. Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S. and Iwasaki, A., Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. USA 2011. 108: 5354-5359.
72. Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., Paley, M. A. et al., Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012. 37: 158-170.
73. Ganal, S. C., Sanos, S. L., Kallfass, C., Oberle, K., Johner, C., Kirschning, C., Lienenklaus, S. et al., Priming of natural killer cells by nonmucosal mononuclear phagocytes requires instructive signals from commensal microbiota. Immunity 2012. 37: 171-186.
74. Ramirez-Ortiz, Z. G., Lee, C. K., Wang, J. P., Boon, L., Specht, C. A. and Levitz, S. M., A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe 2011. 9: 415-424.
75. Mircescu, M. M., Lipuma, L., van Rooijen, N., Pamer, E. G. and Hohl, T. M., Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J. Infect. Dis. 2009. 200: 647-656.
76. Clarke, T. B., Davis, K. M., Lysenko, E. S., Zhou, A. Y., Yu, Y. and Weiser, J. N., Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat. Med. 2010. 16: 228-231.
77. Schuh, J. M., Power, C., Proudfoot, A. E., Kunkel, S. L., Lukacs, N. W. and Hogaboam, C. M., Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice. FASEB J. 2002. 16: 1313-1315.
78. Lilly, L. M., Gessner, M. A., Dunaway, C. W., Metz, A. E., Schwiebert, L., Weaver, C. T., Brown, G. D. et al., The beta-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. J. Immunol. 2012. 189: 3653-3660.
79. Yu, S., Kim, H. Y., Chang, Y. J., DeKruyff, R. H. and Umetsu, D. T., Innate lymphoid cells and asthma. J. Allergy Clin. Immunol. 2014. 133: 943-950; quiz 951.
80. Sonnenberg, G. F. and Artis, D., Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012. 37: 601-610.
81. Crellin, N. K., Trifari, S., Kaplan, C. D., Satoh-Takayama, N., Di Santo, J. P. and Spits, H., Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 2010. 33: 752-764.
82. Hill, D. A., Siracusa, M. C., Abt, M. C., Kim, B. S., Kobuley, D., Kubo, M., Kambayashi, T. et al., Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat. Med. 2012. 18: 538-546.
83. Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C. et al., Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 2014. 20: 159-166.
84. Karimi, K., Inman, M. D., Bienenstock, J. and Forsythe, P., Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am. J. Respir. Crit. Care Med. 2009. 179: 186-193.
85. Jang, S. O., Kim, H. J., Kim, Y. J., Kang, M. J., Kwon, J. W., Seo, J. H., Kim, H. Y. et al., Asthma prevention by Lactobacillus rhamnosus in a mouse model is associated with CD4(+)CD25(+)Foxp3(+) T cells. Allergy Asthma Immunol. Res. 2012. 4: 150-156.
86. Lyons, A., O'Mahony, D., O'Brien, F., MacSharry, J., Sheil, B., Ceddia, M., Russell, W. M. et al., Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin. Exp. Allergy 2010. 40: 811-819.
87. MacSharry, J., O'Mahony, C., Shalaby, K. H., Sheil, B., Karmouty-Quintana, H., Shanahan, F. and Martin, J. G., Immunomodulatory effects of feeding with Bifidobacterium longum on allergen-induced lung inflammation in the mouse. Pulm. Pharmacol. Ther. 2012. 25: 325-334.